df176ce612
Co-Authored-By: Claude Opus 4.8 <noreply@anthropic.com>
72 lines
2.5 KiB
Markdown
72 lines
2.5 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Provides for the restriction of substances in menstrual products"
|
||
description: "Restricts certain substances from being used in menstrual products; relates to the effectiveness of such provisions."
|
||
jurisdiction: "us/states/ny"
|
||
legislature: "New York Legislature"
|
||
session: "2025-2026"
|
||
identifier: "A 9503"
|
||
citation: "New York A 9503 (2025-2026)"
|
||
classification: ["bill"]
|
||
subjects: []
|
||
status: "enacted"
|
||
primary_sponsors: ["Linda Rosenthal"]
|
||
version_count: 1
|
||
action_count: 14
|
||
vote_count: 2
|
||
first_action: "2026-01-08"
|
||
last_action: "2026-02-13"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/b9624f55-1dfd-4a1b-a077-d6b8d64408e1"
|
||
source_url: "http://www.nysenate.gov/legislation/bills/2025/A9503"
|
||
source_hash: "f8573f381d206667eab5fca53456981cddd5675952273daf98a0c61f8455d5aa"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-ny"]
|
||
---
|
||
|
||
# New York A 9503 (2025-2026) — Provides for the restriction of substances in menstrual products
|
||
|
||
Restricts certain substances from being used in menstrual products; relates to the effectiveness of such provisions.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **A9503** (committee substitute) — [source](http://assembly.state.ny.us/leg/?sh=printbill&bn=A9503&term=2025&Text=Y)
|
||
|
||
## Votes
|
||
|
||
- Floor Vote — **59–0** (pass) · upper
|
||
- Assembly Vote — **140–0** (pass) · lower
|
||
|
||
## Sponsors
|
||
|
||
- Linda Rosenthal — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-08** REFERRED TO HEALTH `referral-committee`
|
||
- **2026-01-20** REPORTED REFERRED TO RULES `referral-committee`
|
||
- **2026-01-21** REPORTED
|
||
- **2026-01-21** RULES REPORT CAL.53
|
||
- **2026-01-21** ORDERED TO THIRD READING RULES CAL.53
|
||
- **2026-01-21** PASSED ASSEMBLY `passage`
|
||
- **2026-01-21** DELIVERED TO SENATE
|
||
- **2026-01-21** REFERRED TO RULES `referral-committee`
|
||
- **2026-01-28** SUBSTITUTED FOR S8816
|
||
- **2026-01-28** 3RD READING CAL.91
|
||
- **2026-01-28** PASSED SENATE `passage`
|
||
- **2026-01-28** RETURNED TO ASSEMBLY
|
||
- **2026-02-13** DELIVERED TO GOVERNOR `executive-receipt`
|
||
- **2026-02-13** SIGNED CHAP.31 `executive-signature`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/b9624f55-1dfd-4a1b-a077-d6b8d64408e1`. Confidence: reported (aggregated from official New York legislature records).
|
||
|